Center for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, Cape Town.
Division of Medical Microbiology and the Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Int J Tuberc Lung Dis. 2019 Feb 1;23(2):125-135. doi: 10.5588/ijtld.18.0866.
The drug-resistant tuberculosis (DR-TB) cascade-from estimated or incident cases to numbers successfully treated or disease-free survival-has long been characterised by sharp declines at each step in the cascade. The losses along the cascade vary across different settings, and the reasons why some countries have a higher burden of DR-TB are complex and multifactorial; broadly, weak health systems, inadequate financing and poverty all impact differential access to DR-TB care. Within a human rights framework that mandates the right to health and the right to benefit from scientific progress, the aim of this review is to focus on describing inequities in access to DR-TB care at critical points in the cascade.
耐多药结核病（DR-TB）的传播过程——从预估或新发病例到成功治疗或无疾病生存的人数——长期以来，每一步都呈现出急剧下降的特征。传播过程中的损失因不同的环境而有所不同，而一些国家耐多药结核病负担更高的原因是复杂的、多因素的；总的来说，薄弱的卫生系统、资金不足和贫困都影响了获得耐多药结核病护理的机会。在一个要求健康权和从科学进步中受益的人权框架内，本综述的目的是重点描述在传播过程的关键节点上，获得耐多药结核病护理的机会存在的不平等现象。
